The short version
- Employers are re-tendering: in Business Group on Health’s 2026 survey (opens in a new tab) of 121 large employers, 51% were changing or running a request for proposal (RFP) for health and well-being vendors, as they projected a median 9% cost increase.
- Purchasers keep buying but demand proof: in a Peterson Health Technology Institute survey (opens in a new tab) of 332 health plans, employers and provider organizations, 75% were spending more on digital health than two years earlier, and employers evaluated vendors on health outcomes (99%) and costs (93%).
- Contracts come up for renewal often: most digital health contracts in that survey ran two years or less, and 59% of employers contracted directly with vendors.
- Independent evaluation shapes categories: the institute found that physical therapist-guided virtual programs for back pain could save an estimated $4.4 million per 1 million (opens in a new tab) commercially insured people, after finding earlier that many diabetes tools did not deliver clinical benefits.
- The winners are growing fast: Hinge Health reported 2,929 clients in mid-2026, up 24% in a year, and second-quarter revenue up 53%.
A note before you read: this article is about how healthtech companies are found and described by AI assistants. It makes no health or clinical claims, and nothing here is medical, legal or regulatory advice. Consumer health apps sold directly to people are a different market; hospital IT is covered in our healthcare software article.
Who buys healthtech, and what is a customer worth?
Employers, health plans and provider organizations buy the contract; their employees or members then have to enroll.
The purchaser survey from the Peterson Health Technology Institute (PHTI), summarized by Jeff Levin-Scherz in his Employer Coverage newsletter, covered 115 health plans, 117 employers and 100 health care delivery organizations. Among employers, more than half bought digital programs for diabetes (78%), obesity (63%) and mental health (57%). Direct contracting was the most common route for health plans (63%) and employers (59%), followed by contracting through a pharmacy benefit manager (PBM) at 30%.
That gives most healthtech companies two sales. The first is the contract with the employer or plan, often through a benefits consultant or a channel partner. The second is each employee or member who signs up, because revenue usually follows enrollment.
Public companies show what a customer is worth when both sales work:
- Hinge Health, a virtual musculoskeletal care company, had 2,929 clients on June 30, 2026, against 2,359 a year earlier, and second-quarter revenue of $212.8 million. It counts organizations that buy through its partners as individual clients, a sign of how much reach channel partners provide.
- Omada Health, a cardiometabolic care company, reported second-quarter revenue of $88 million (opens in a new tab), up 43%, total members up 45%, and trailing twelve-month revenue per member of $284.
One employer contract can therefore bring thousands of members, each worth a recurring fee for as long as the program is renewed. Platforms that also sell virtual care to health systems are covered in how virtual care platforms win contracts.
Why are employers and health plans re-examining vendors now?
Because costs are rising fast, and buyers are cutting programs that cannot prove their value.
Business Group on Health’s survey covered employers with 11.6 million people on their plans. They projected a median 9% cost increase for 2026, cut to 7.6% after plan design changes, and the group’s chief executive said employers would be “rigorously evaluating benefit offerings, vendor performance and patient outcomes.” Besides the 51% reviewing health and well-being vendors, 41% were changing pharmacy benefit managers or running an RFP.
Evidence now separates categories. PHTI reported that virtual musculoskeletal programs improved pain and function, with physical therapist-guided programs saving money. Its earlier review of digital diabetes tools found that many did not provide clinical benefits. In the newsletter’s summary of the purchaser survey, only 47% of buyers who increased spending said digital health had decreased their costs, and its author warned that vendor claims of savings might not hold up in practice.
Our inference: in a market where buyers check claims against independent evaluations, what assistants say about a category and its evidence will shape who makes the longlist. Younger companies face that check with less coverage behind them, as our guide on how healthcare startups compete with big brands explains.
Where does AI search enter a healthtech purchase?
Early, at the research and longlist stage, though no public survey yet measures benefits buyers specifically.
Across business purchases, a Gartner survey of 645 B2B buyers (opens in a new tab) found 45% had used generative AI during a recent purchase, primarily to gather information on vendors and products, and 69% preferred to validate AI-generated insights with sales reps. We found no comparable figure for benefits leaders, consultants or health plan buyers, and we do not assume one.
A reasonable expectation is that AI enters at three points:
- Category research. A benefits manager asked to “look at virtual MSK” or “find a GLP-1 support program” starts by asking what the options are.
- Longlist and RFP drafting. Consultants and procurement teams compare vendors on evidence, guarantees and integration.
- Member questions. After launch, employees ask whether a program is legitimate, private and free through their employer. In our study of “is it legit?” questions, 88.0% of AI answers cited a review or complaint platform.
The third point is easy to miss. A contract won in the RFP still depends on enrollment, and enrollment depends partly on what members hear when they check.
What do employers, plans and members ask AI about healthtech vendors?
Questions about evidence, savings, guarantees, privacy and fit. We drafted the prompts below to show typical questions from benefits teams, plans and members; none was collected from a real buyer.
| Buyer | Illustrative prompt |
|---|---|
| Benefits leader | “Which virtual physical therapy programs have independent evidence of lower costs for self-insured employers?” |
| Benefits consultant | “Compare Hinge Health and Sword Health on outcomes, pricing model and guarantees” |
| Health plan | “Digital diabetes programs with peer-reviewed results and fees tied to outcomes” |
| Employer, GLP-1 costs | “Weight management programs that work alongside GLP-1 coverage, with outcome guarantees” |
| Provider organization | “Remote monitoring vendors for hypertension that integrate with Epic” |
| Member | “Is [program] really free through my employer, and who sees my health data?” |
Notice how many ask for proof: independent evidence, peer-reviewed results, guarantees. A vendor whose evidence exists only in a sales deck gives an assistant nothing to repeat.
How does an AI mention turn into contract value and enrollment?
By putting the vendor on the longlist, then supporting the evidence review, launch and every renewal after it.
The path runs: an AI answer during category research → the vendor appears on the consultant’s or employer’s longlist → evidence and savings review → a pilot or contract with risk-based terms → launch → employee enrollment → renewal. Because most contracts run two years or less, the evaluation repeats often, and each renewal is another moment when a buyer may ask what the market looks like now.
Being missing has a cost, though no one has measured it in dollars. Our inference: a vendor left out of category answers loses a place on longlists during a year when 51% of large employers are reviewing well-being vendors, and a vendor described with outdated or unsupported claims risks failing the evidence review that follows. The broader pattern of how early AI answers shape shortlists is covered in are AI assistants now shaping which enterprise software gets shortlisted?
What decides whether an assistant names a healthtech vendor?
Platforms do not document how vendors are chosen; studies point to independent coverage and evidence.
Documented by platforms. No assistant publishes how it selects vendors in a category. We found nothing specific to healthtech.
Observed in a study. In our brand study, independent coverage was the strongest predictor we measured: each tenfold increase in independent sites naming a brand in the cited pages went with 4.7 times the odds of being recommended. That study covered consumer brands, not health services.
Our inference for healthtech. Buyers in this market already trust independent evaluators, peer-reviewed studies, consultants and trade coverage more than vendor claims. We expect assistants to reflect the same sources when they describe a category, which means:
- Independent evaluations travel. A PHTI assessment, a peer-reviewed trial or a published validation is the kind of source an assistant can cite when asked which programs work.
- Category position matters. PHTI evaluated eight virtual musculoskeletal solutions in one report. If an evaluator groups you in a category, that grouping may shape how you are described.
- Unsupported claims are a risk. Our article on how often AI answers say things their sources do not support shows how easily a claim drifts from its evidence; precise, sourced statements are harder to distort.
How does GEO work for a healthtech company?
Generative engine optimization (GEO) for healthtech means making your evidence, terms and fit easy to find, verify and quote.
- Evidence pages for buyers. Summaries of each study with a link, who ran it, the population, the measure and its limits. Name independent evaluations, including unfavorable ones you have answered.
- Savings and guarantee terms in plain words. How fees work, what is guaranteed, how savings are calculated. Buyers ask for this; vague claims invite doubt.
- Category explainers. An honest guide to the category, how to compare vendors and what evidence to ask for. These pages can be cited even when the question does not name you.
- Security and privacy facts. Certifications, data handling and what members’ employers can and cannot see, on public pages.
- Channel and partner listings. Health plan, PBM and benefits platform listings that describe you accurately and consistently.
- Coverage where buyers read. Benefits and health plan trade press, consultant briefings, conference talks and peer-reviewed publications, so independent sources describe you in your category.
- Member-facing pages and reviews. Eligibility, cost to the member and privacy, written for employees, plus reviews and complaint responses handled well.
- Regular checks. Ask employer, consultant, plan and member questions across assistants before RFP season and open enrollment, and track who is named and which sources are cited.
The approach overlaps with how brands build authority for AI search, with one difference: every claim must survive a clinical and actuarial review. GEO cannot guarantee that an assistant names any vendor; it makes your evidence easier to find and harder to misstate.
What does no one know yet about AI in healthtech buying?
Whether AI answers change which vendors win contracts; the evidence so far is indirect.
- No benefits-buyer data. The AI-use figures come from cross-industry B2B surveys, not from employers, consultants or health plans.
- Older purchaser data. The PHTI purchaser survey was published in October 2024.
- Consumer-brand studies. Our brand study tested consumer products, not health services sold to employers.
- No contract link. We found no public data connecting AI visibility to RFP invitations, contracts or enrollment.
- Company figures are self-reported. Client and member counts come from company releases.
Where should a healthtech company start?
Start by asking assistants the category, comparison and member questions your buyers ask before the next RFP cycle.
List the questions a benefits leader, a consultant, a health plan and a member would ask about your category. Put each question to ChatGPT, Gemini, Perplexity and Google AI Mode, the way a benefits consultant building a vendor shortlist might. Note which vendors are named, which evidence is cited, whether your outcomes and terms are described correctly, and what members hear when they ask if you are legitimate.
If your growth depends on employer contracts, plan partnerships and enrollment, ask us to test what AI tells your buyers and members. We will map how assistants describe your category and your evidence, find the gaps and errors, and plan the evidence, coverage and listing work that supports your next RFP and renewal season. For the full scope, our generative engine optimization service page explains how that program is diagnosed, carried out and measured for vendors selling to employers and health plans.
Frequently asked questions
Do employers use ChatGPT to choose health benefit vendors?
No public survey measures this yet. Across B2B purchases, 45% of buyers in a Gartner survey used generative AI, mainly to gather information on vendors and products.
Does an independent evaluation help a healthtech company in AI answers?
Probably, though it is not proven. Independent sources are what buyers trust, and in our brand study independent coverage was the strongest predictor of being recommended.
Should we publish our pricing and guarantees?
Publish how fees and guarantees work, at least in outline. Buyers ask assistants about them, and 93% of employers in one survey evaluated vendors on costs.
Do member reviews matter if we sell to employers?
Yes, because enrollment drives revenue. When people ask AI whether a company is legitimate, 88.0% of answers in our study cited a review or complaint platform.
Sources
- Business Group on Health (2025-08-19), Business Group on Health Survey: 9% Health Care Cost Increase for 2026 (opens in a new tab)
- Employer Coverage, Jeff Levin-Scherz (2024-10), Survey shows growing interest in digital health (opens in a new tab)
- TechTarget (2024-06), PHTI validates virtual MSK solutions after taking diabetes tools to task (opens in a new tab)
- Hinge Health (2026-08-04), Hinge Health reports record second quarter 2026 financial results
- Omada Health, via BioPharmaWatch (2026-08), Omada Health Q2 2026 results (opens in a new tab)
- Gartner (2026-05-20), Gartner Survey Finds 69% of B2B Buyers Turn to Sales Reps to Validate AI-Generated Insights (opens in a new tab)
- Underneath (2026), Do Wikipedia and schema make AI assistants recommend a brand?
- Underneath (2026), “Is this brand legit?” How AI assistants build a reputation